{ "cik": 1124105, "cik_padded": "0001124105", "entityName": "GYRE THERAPEUTICS, INC.", "fiscal_years": [ { "accn": "0001193125-26-106251", "filed": "2026-03-13", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1190000.0, "cash": 37070000.0, "eps_diluted": 0.02, "free_cash_flow": -180000.0, "net_income": 9880000.0, "operating_cash_flow": 1010000.0, "operating_income": 11487000.0, "revenue": 116588000.0, "stockholders_equity": 106031000.0, "total_assets": 166132000.0, "total_liabilities": 23850000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.22493421735152927, "net_margin": 0.08474285518235153, "operating_margin": 0.09852643496757814, "revenue_growth_yoy": 0.10241402460357234, "roa_avg2y": 0.06777847141710515, "roa_period_end": 0.05947078226952062, "roe_avg2y": 0.11668142899320932, "roe_period_end": 0.09318029632843224 } }, { "accn": "0001193125-26-106251", "filed": "2026-03-13", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2315000.0, "cash": 11813000.0, "cost_of_revenue": 3884000.0, "eps_diluted": 0.05, "free_cash_flow": -5956000.0, "gross_profit": 101873000.0, "net_income": 17898000.0, "operating_cash_flow": -3641000.0, "operating_income": 16163000.0, "revenue": 105757000.0, "stockholders_equity": 63319000.0, "total_assets": 125406000.0, "total_liabilities": 27004000.0 }, "period_end": "2024-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.9632742986279867, "leverage": 0.42647546550008686, "net_margin": 0.16923702449956032, "operating_margin": 0.15283149105969346, "revenue_growth_yoy": -0.06780960775672103, "roa_avg2y": 0.14795098059476328, "roa_period_end": 0.14272044399789482, "roe_avg2y": 0.7537428144279968, "roe_period_end": 0.282663971319825 } }, { "accn": "0000950170-25-040279", "filed": "2025-03-17", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 8517000.0, "cash": 33509000.0, "cost_of_revenue": 4636000.0, "eps_diluted": -1.41, "free_cash_flow": 17375000.0, "gross_profit": 108814000.0, "net_income": -85480000.0, "operating_cash_flow": 25892000.0, "operating_income": -67230000.0, "revenue": 113450000.0, "stockholders_equity": -15828000.0, "total_assets": 116539000.0, "total_liabilities": 38065000.0 }, "period_end": "2023-12-31", "ratio_units": { "gross_margin": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": 0.9591361833406787, "net_margin": -0.7534596738651388, "operating_margin": -0.5925958572058175, "revenue_growth_yoy": 0.10910157395639848, "roa_avg2y": -0.8493134352085527, "roa_period_end": -0.7334883601197881, "roe_avg2y": -6.404435453659999 } }, { "accn": "0000950170-24-037242", "filed": "2024-03-27", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 4985000.0, "cash": 25175000.0, "cost_of_revenue": 4793000.0, "eps_diluted": 0.03, "free_cash_flow": 5692000.0, "gross_profit": 97497000.0, "net_income": 4314000.0, "operating_cash_flow": 10677000.0, "operating_income": 9203000.0, "revenue": 102290000.0, "stockholders_equity": 42522000.0, "total_assets": 84753000.0, "total_liabilities": 12536000.0 }, "period_end": "2022-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.9531430247336006, "leverage": 0.2948120972672969, "net_margin": 0.042174210577769086, "operating_margin": 0.08996969400723433, "revenue_growth_yoy": 12.939765603706732, "roa_avg2y": 0.06144642666381797, "roa_period_end": 0.05090085306714807, "roe_avg2y": 0.10319216371051657, "roe_period_end": 0.10145336531677719 } }, { "accn": "0001564590-23-004830", "filed": "2023-03-30", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 839000.0, "cash": 44347000.0, "eps_diluted": -2.87, "free_cash_flow": -84594000.0, "net_income": -87933000.0, "operating_cash_flow": -83755000.0, "operating_income": -87894000.0, "revenue": 7338000.0, "stockholders_equity": 41089000.0, "total_assets": 55662000.0, "total_liabilities": 14573000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3546691328579425, "revenue_growth_yoy": -0.6497040290242505, "roa_avg2y": -1.1684827384590852, "roa_period_end": -1.5797671661097337, "roe_avg2y": -1.5011010771778281, "roe_period_end": -2.1400618170313224 } }, { "accn": "0001564590-23-004830", "filed": "2023-03-30", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 30360000.0, "net_income": -56241000.0, "operating_cash_flow": -55048000.0, "operating_income": -57370000.0, "revenue": 20948000.0, "stockholders_equity": 76069000.0, "total_assets": 94846000.0, "total_liabilities": 18777000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.2468416832086658, "roa_avg2y": -0.5816028955532575, "roa_period_end": -0.5929717647554984, "roe_avg2y": -0.7789342474291057, "roe_period_end": -0.7393419132629586 } }, { "accn": "0001564590-22-012877", "filed": "2022-03-31", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 64000.0, "cash": 15369000.0, "free_cash_flow": -43677000.0, "net_income": -55178000.0, "operating_cash_flow": -43613000.0, "operating_income": -57277000.0, "stockholders_equity": 68336000.0, "total_assets": 98554000.0, "total_liabilities": 30218000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.4421973776633107, "roa_avg2y": -0.49382031019268463, "roa_period_end": -0.5598758041276863, "roe_avg2y": -0.586123931782814, "roe_period_end": -0.8074514165300868 } }, { "accn": "0001564590-21-010823", "filed": "2021-03-04", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 376000.0, "cash": 31213000.0, "free_cash_flow": -28929000.0, "net_income": -30055000.0, "operating_cash_flow": -28553000.0, "operating_income": -33822000.0, "revenue": 6000.0, "stockholders_equity": 119945000.0, "total_assets": 124920000.0, "total_liabilities": 4975000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.04147734378256701, "revenue_growth_yoy": -0.9941060903732809, "roa_avg2y": -0.36555922472982916, "roa_period_end": -0.24059398014729427, "roe_avg2y": -0.3988216482328041, "roe_period_end": -0.2505731793738797 } }, { "accn": "0001564590-20-005546", "filed": "2020-02-20", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 23000.0, "cash": 14472000.0, "free_cash_flow": -19963000.0, "net_income": -21561000.0, "operating_cash_flow": -19940000.0, "operating_income": -21822000.0, "revenue": 1018000.0, "stockholders_equity": 30774000.0, "total_assets": 39513000.0, "total_liabilities": 8739000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.283973484109963, "roa_avg2y": -0.5556743940311586, "roa_period_end": -0.5456685141598967, "roe_avg2y": -0.9205251360870957, "roe_period_end": -0.7006239032949892 } }, { "accn": "0001564590-19-006879", "filed": "2019-03-08", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "net_income": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 468000.0, "cash": 10264000.0, "net_income": -16945000.0, "operating_income": -20418000.0, "stockholders_equity": 16071000.0, "total_assets": 38090000.0, "total_liabilities": 22019000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.3701076473150395, "roa_period_end": -0.44486741927014967, "roe_period_end": -1.0543836724534876 } }, { "accn": "0001564590-17-003722", "filed": "2017-03-08", "fiscal_year": 2015, "form": "10-K", "fundamental_units": { "capex": "USD" }, "fundamentals": { "capex": 272000.0 }, "period_end": "2015-12-31", "ratios": {} }, { "accn": "0001193125-14-099974", "filed": "2014-03-14", "fiscal_year": 2013, "form": "10-K", "fundamental_units": { "operating_cash_flow": "USD" }, "fundamentals": { "operating_cash_flow": -40612000.0 }, "period_end": "2013-12-31", "ratios": {} }, { "accn": "0001193125-13-109464", "filed": "2013-03-15", "fiscal_year": 2012, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares" }, "fundamentals": { "eps_diluted": -0.21 }, "period_end": "2012-12-31", "ratios": {} }, { "accn": "0001193125-13-109464", "filed": "2013-03-15", "fiscal_year": 2011, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares" }, "fundamentals": { "eps_diluted": -0.27 }, "period_end": "2011-12-31", "ratios": {} }, { "accn": "0001193125-13-109464", "filed": "2013-03-15", "fiscal_year": 2010, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares" }, "fundamentals": { "eps_diluted": 0.36 }, "period_end": "2010-12-31", "ratios": {} }, { "accn": "0001193125-12-099259", "filed": "2012-03-06", "fiscal_year": 2009, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares" }, "fundamentals": { "eps_diluted": -1.54 }, "period_end": "2009-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001193125-26-106251", "filed": "2026-03-13", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001124105.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001124105.json" }, "ticker": "GYRE" }